A detailed history of Logos Global Management LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Logos Global Management LP holds 3,500,000 shares of OCUL stock, worth $34.2 Million. This represents 4.03% of its overall portfolio holdings.

Number of Shares
3,500,000
Previous 5,150,000 32.04%
Holding current value
$34.2 Million
Previous $35.2 Million 13.56%
% of portfolio
4.03%
Previous 3.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.45 - $9.23 $10.6 Million - $15.2 Million
-1,650,000 Reduced 32.04%
3,500,000 $30.4 Million
Q2 2024

Aug 14, 2024

SELL
$4.2 - $8.69 $2.78 Million - $5.75 Million
-661,436 Reduced 11.38%
5,150,000 $35.2 Million
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $6.97 Million - $19.8 Million
1,811,436 Added 45.29%
5,811,436 $52.9 Million
Q4 2023

Feb 14, 2024

BUY
$2.08 - $4.52 $8.32 Million - $18.1 Million
4,000,000 New
4,000,000 $17.8 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $752M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.